Background In patients with post-acute COVID-19 syndrome (PACS), abnormal gas-transfer
and pulmonary vascular density have been reported, but such findings have not been …

The respiratory consequences of acute COVID‐19 infection and related symptoms tend to
resolve 4 weeks post‐infection. However, for some patients, new, recurrent, or persisting …

Purpose Some patients experience long-term sequelae after infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). However, despite a present post-COVID …

In survivors of severe coronavirus disease 2019 (COVID-19) incomplete mental and
physical recovery may considerably impact daily activities and health-related quality of life …

Background: SARS-CoV-2 has infected millions across the globe. Many individuals are left
with persistent symptoms, termed post-acute sequelae of COVID-19 (PASC), for months after …

Post-COVID-19 pulmonary sequalae are well-recognized early in the pandemic.
Survivorship clinics are crucial for managing at-risk patients. However, it is unclear who …

Little data exist on long COVID outcomes beyond one year. In a cohort enrolled with mild-
moderate acute COVID-19, a wide range of symptoms manifest at 6, 12, and 18 months …

Post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)(PASC) is a complex condition with multisystem involvement. We assessed patients' …

The human immunodeficiency virus (HIV) continues to pose a significant global health
challenge, with millions of people affected and new cases emerging each year. While …

BACKGROUND: Although the number of new cases of coronavirus 2019 (COVID-19) has
been drastically reduced worldwide, patients who demonstrate long-term symptoms need …